Improved Homogenization of Recombinant Escherichia coli following Pretreatment with Guanidine Hydrochloride

Stuart M. Bailey, Paul H. Blum, Michael M. Meagher

Research output: Contribution to journalArticle

27 Scopus citations

Abstract

Pretreatment of recombinant Escherichia coli, expressing human growth hormone inclusion bodies, with guanidine hydrochloride and Triton X‐100 prior to high‐pressure homogenization has been investigated. Homogenates were analyzed for protein release, viscosity, and particle size. We were able to reduce the number of passes required for cell disruption and the number of downstream processing steps required for the recovery of protein from inclusion bodies by pretreating cells with guanidine HCl and Triton X‐100. Pretreatment of exponential growth phase cells with 1.5 M guanidine HCl and 1.5% Triton X‐100 gave adequate disruption after one pass at 41 MPa with a particle size distribution similar to that for untreated cells disrupted after one pass at 62 MPa. This combination of guanidine HCl and Triton X‐100 was also selected so as to wash the inclusion bodies without solubilization of the human growth hormone. Pretreatment of cells with 4 M guanidine HCl produced cell debris that was substantially smaller than the debris from untreated cells and partially solubilized the inclusion bodies. Cells harvested in the stationary growth phase were more resistant to high‐pressure homogenization and pretreatment.

Original languageEnglish (US)
Pages (from-to)533-539
Number of pages7
JournalBiotechnology Progress
Volume11
Issue number5
DOIs
StatePublished - Jan 1 1995

ASJC Scopus subject areas

  • Biotechnology

Fingerprint Dive into the research topics of 'Improved Homogenization of Recombinant Escherichia coli following Pretreatment with Guanidine Hydrochloride'. Together they form a unique fingerprint.

  • Cite this